Effects of ouabain and diphenylhydantoin myocardial potassium balance in man.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D001024:Aortic Valve Stenosis / Q000378:metabolism / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D009202:Cardiomyopathies / Q000378:metabolism / Q000503:physiopathology; D003327:Coronary Disease / Q000378:metabolism / Q000503:physiopathology; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D006801:Humans; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism*; D010042:Ouabain / Q000494:pharmacology*; D010672:Phenytoin / Q000494:pharmacology*; D011188:Potassium / Q000097:blood / Q000378:metabolism*; D012214:Rheumatic Heart Disease / Q000378:metabolism / Q000503:physiopathology; D012964:Sodium / Q000378:metabolism
D010042:Ouabain; D010672:Phenytoin; D012964:Sodium; D000251:Adenosine Triphosphatases; D011188:Potassium